Previous studies by our research group have shown that dapagliflozin has a good therapeutic effect on rabbits with chronic heart failure, but the mechanism of inhibiting ferroptosis and improving chronic heart failure through the regulation of the Nrf2/HO-1/GPX4 signaling pathway remains unclear. The gene discussed is GPX4; the disease is congestive heart failure.